Nevertheless, recent discoveries showing that hypoxia negatively impacts the tumor immune response by modifying the expression of main immune checkpoints (e.g., PD-L1, CD47, PD-1, HLA-G, ...) provide a major opportunity for innovative combination approaches. The gene discussed is PDCD1; the disease is neoplasm.